XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenues:        
Product $ 17,175 $ 28,056 $ 65,633 $ 107,387
Service 839 1,008 2,399 2,832
Total revenues 18,014 [1] 29,064 [1] 68,032 [1] 110,219 [1]
Cost of revenues:        
Cost of product 7,348 [2] 16,672 [2] 32,984 [2] 63,352 [2]
Cost of service 211 [2] 493 [2] 862 [2] 1,601 [2]
Total cost of revenues 7,559 17,165 33,846 64,953
Gross profit 10,455 11,899 34,186 45,266
Operating expenses:        
Product development 5,294 [2] 7,256 [2] 17,160 [2] 23,450 [2]
Sales and marketing 3,991 [2] 4,807 [2] 12,504 [2] 16,512 [2]
General and administrative 3,925 [2] 3,679 [2] 11,045 [2] 11,624 [2]
Litigation Charges 0 0 3,452 0
Restructuring charges 0 0 2,522 1,176
Total operating expenses 13,210 15,742 46,683 52,762
Loss from operations (2,755) (3,843) (12,497) (7,496)
Interest and other income (expense), net (606) (184) (486) (194)
Interest expense on lease financing obligations (305) (336) (938) (1,031)
Loss before provision for income taxes (3,666) (4,363) (13,921) (8,721)
Income tax expense 113 57 256 148
Net loss (3,779) (4,420) (14,177) (8,869)
Net loss attributable to non controlling interest 266 156 590 156
Net loss attributable to Echelon Corporation Stockholders $ (3,513) $ (4,264) $ (13,587) $ (8,713)
Net loss per share:        
Basic $ (0.08) $ (0.10) $ (0.32) $ (0.20)
Diluted $ (0.08) $ (0.10) $ (0.32) $ (0.20)
Shares used in computing net loss per share:        
Basic 43,184 42,806 43,039 42,564
Diluted 43,184 42,806 43,039 42,564
[1] Includes related party amounts of $2,523 and $1,768 for the three months ended September 30, 2013 and 2012, respectively, and $8,600 and $3,527 for the nine months ended September 30, 2013 and 2012, respectively. See Note 12 for additional information on related par
[2] See Note 4 for summary of amounts included representing stock-based compensation expense.